CLINICAL_TRIALS
trial_result
· 2021-09-10
Clinical Trial Update: ET-01 in Subjects With Lateral Canthal Lines [Phase 2]
Summary
Phase 2 clinical trial update for ET-01 in subjects with lateral canthal lines (crow's feet) with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eirion Therapeutics Inc. | Conditions: Lateral Canthal Lines, Crow's Feet | Phase 2 | Status: COMPLETED | Results posted: 2021-09-10